Management of Atrial Fibrillation in Patients with Cardiac Devices

Introduction to Pacemaker Management

The American Heart Association recommends assessing pacemaker dependency status before testing to ensure safe exercise testing in patients with cardiac devices 1
Exercise testing in patients with pacemakers is safe and provides valuable information, including assessing chronotropic incompetence and deciding on optimal pacing mode, according to the American Heart Association 1

Continuous monitoring and proper precautions, such as having external defibrillation equipment readily available and personnel trained in advanced cardiac life support, are necessary to ensure safe exercise testing in patients with pacemakers 1
Pacemaker-dependent patients require additional precautions, such as programming to an asynchronous mode, to ensure safe exercise testing, as indicated by the American Heart Association guidelines 1

When evaluating a patient for conscious sedation, assess the degree of fatigue, level of consciousness, presence of obstructive sleep apnea (OSA), and review the patient's cardiovascular status and pacemaker dependency, as sleep deprivation may increase sensitivity to sedative medications, as recommended by the European Heart Society 2, 3
Blood pressure monitoring should be performed every 3-5 minutes, and pulse oximetry should be used to detect early signs of respiratory depression, with assessment of level of sedation frequently using a standardized scale (e.g., Modified Observer's Assessment of Alertness/Sedation Scale) 4

Pacemaker battery replacement typically takes 30-60 minutes to complete, involving accessing the existing pacemaker pocket, disconnecting the old generator, connecting a new generator, and closing the incision, with a low-risk profile, as described by the American Academy of Dermatology and the European Heart Society 5, 3
Local infiltration with lidocaine 1-2% with or without epinephrine is the standard and preferred method for anesthesia in pacemaker battery replacement, as recommended by the American Academy of Dermatology 5

Extended monitoring period (at least 30-60 minutes longer than standard) is recommended due to potential delayed recovery in sleep-deprived patients, with assessment of pacemaker function and monitoring for signs of oversedation including respiratory depression, as recommended by the European Heart Society 3
Patients should be evaluated for pacemaker syndrome, looking for symptoms like fatigue, dizziness, dyspnea, chest pain, or syncope, especially in cases of elective replacement due to battery depletion, as recommended by the American College of Cardiology 6, 7

Regular follow-up, including increased monitoring frequency during hot seasons and consideration of remote monitoring capabilities, is crucial for patients with pacemaker syndrome, as recommended by the European Society of Cardiology 8
Optimizing pacing mode, considering upgrading from VVI to dual-chamber pacing (DDD) or atrial-based pacing when appropriate, can help restore AV synchrony and reduce heat sensitivity, as recommended by the European Society of Cardiology 8, 7
Discontinuation of pacemaker therapy is reasonable after evaluation of symptoms during a period of monitoring while pacing therapy is off for patients whose original pacing indication has resolved or is in question, as recommended by the American College of Cardiology/American Heart Association 9, 10

The American College of Cardiology, American Heart Association, and Heart Rhythm Society guidelines state that if bradycardia is accompanied by dizziness or lightheadedness or if second- or third-degree heart block occurs, physicians should decrease the dose of the beta-blocker 11